U.S. Markets closed

Stepan Reports Third Quarter Results and Record Nine Month Earnings

NORTHFIELD, Ill. , Oct. 24, 2018 /PRNewswire/ -- Stepan Company ( SCL ) today reported:

Third Quarter Highlights

  • Reported net income was $22.2 million , or $0.95 per diluted share versus $21.9 million , or $0.94 per diluted share, in the prior year. Adjusted net income* was $26.0 million , or $1.11 per diluted share, a 21% increase versus $21.4 million , or $0.92 per diluted share, in the prior year.

  • Consolidated net sales were $508.0 million , an increase of 4% versus the prior year. This increase was primarily attributable to 6% global volume growth. The Company's first quarter acquisition of BASF's production facility in Mexico accounted for 2% and 4% of the quarterly increases in consolidated net sales and global volume growth, respectively. Foreign currency translation negatively impacted net sales by 2% in the quarter.

  • Surfactant operating income was $31.2 million , reflecting record third quarter results, versus $22.6 million in the prior year. The increase was primarily attributable to higher North American demand within the consumer and functional product end markets. Global Surfactant sales volume increased 9% versus the prior year.

  • Polymer operating income was $17.4 million versus $21.1 million in the prior year. This decrease was mostly attributable to margin pressures and lower European volume. Global Polymer sales volume was down 1% versus prior year. Global rigid polyol volume growth of 4% mostly offset lower volumes in other end markets.

  • Specialty Product operating income was up $1.7 million versus the prior year primarily due to order timing differences within our pharmaceutical and flavor businesses.

  • The Company's net-debt ratio declined to 2%.

  • The Company increased its quarterly cash dividend in the fourth quarter of 2018 by $.025 per share, or 11%, marking the 51st consecutive year that the Company has increased its cash dividend to stockholders.

YTD Highlights

  • Reported net income was a record $85.8 million , or $3.68 per diluted share, up 5% versus $81.7 million , or $3.50 per diluted share, in the prior year. Adjusted net income* was a record $90.1 million , or $3.86 per diluted share, a 7% increase versus $84.0 million , or $3.60 per diluted share, in the prior year. Total Company sales volume increased 4% compared to the first nine months of 2017.

*  Adjusted net income is a non-GAAP measure which excludes Deferred Compensation income/ expense as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

"The Company delivered record results through the first nine months.  These results have been driven by record Surfactant earnings and a lower 2018 effective tax rate," said F. Quinn Stepan, Jr. , Chairman, President and Chief Executive Officer.   "The quarterly and year-to-date Surfactant growth reflects higher sales volume, improved product mix and lower manufacturing costs.  During the third quarter the Company approved a plan to cease Surfactant production at our German plant to further reduce our fixed cost base, refocus Surfactant resources on higher margin end markets and allow for select assets to be repurposed to support future polyol growth.  The Polymer business remains down versus the prior year due to continued margin challenges and the lingering effects of the 2017 MDI shortage in Europe.  Global rigid polyol volumes were up 4% versus the prior year quarter.  Our Specialty Product business results were up for the quarter due to the partial catch up of order timing differences encountered in the first half of the year."

Financial Summary



Three Months Ended

September 30

Nine Months Ended

September 30


($ in thousands, except per share data)


2018


2017

%

Change



2018


2017


%

Change


Net Sales

$

507,997


$

487,814


4

%


$

1,527,198


$

1,451,184



5

%

Operating Income

$

27,694


$

30,434


(9)

%


$

112,034


$

115,797



(3)

%

Net Income

$

22,168


$

21,899


1

%


$

85,816


$

81,694



5

%

Earnings per Diluted Share

$

0.95


$

0.94


1

%


$

3.68


$

3.50



5

%




















Adjusted Net Income *

$

25,965


$

21,448


21

%


$

90,109


$

84,041



7

%

Adjusted Earnings per Diluted Share *

$

1.11


$

0.92


21

%


$

3.86


$

3.60



7

%



* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

Summary of Third Quarter Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income/expense as well as certain other significant and infrequent or non-recurring items.

  • Deferred Compensation: The current year third quarter reported net income includes $2.6 million of after-tax expense versus $0.8 million of after-tax income in the prior year.
  • Business Restructuring: The current year third quarter reported net income includes $1.0 million of after-tax asset and spare parts write-downs related to the third quarter shutdown of Surfactant operations at our German plant site and $0.2 million of after-tax decommissioning expense related to our prior year Canadian plant closure. The $0.3 million after-tax expense in the prior period was due to Canadian plant closure decommissioning.

Percentage Change in Net Sales

The 4% increase in quarterly net sales was primarily attributable to 6% sales volume growth partially offset by the negative impact of foreign currency translation.



Three Months Ended

September 30, 2018



Nine Months Ended

September 30, 2018


Volume



6

%



4

%

Selling Price



0

%



0

%

Foreign Translation



(2)

%



1

%

Total



4

%



5

%

Reported Segment Results



Three Months Ended

September 30

Nine Months Ended

September 30


($ in thousands)


2018


2017


%

Change



2018


2017


%

Change


Net Sales





















Surfactants


$

346,884


$

321,444



8

%


$

1,062,708


$

973,381



9

%

Polymers


$

141,646


$

147,754



(4)

%


$

404,446


$

415,551



(3)

%

Specialty Products


$

19,467


$

18,616



5

%


$

60,044


$

62,252



(4)

%

Total Net Sales


$

507,997


$

487,814



4

%


$

1,527,198


$

1,451,184



5

%


Three Months Ended

September 30

Nine Months Ended

September 30


($ in thousands, all amounts pre-tax)

2018


2017


%

Change



2018


2017


%

Change


Operating Income *




















Surfactants

$

31,201


$

22,559



38

%


$

105,670


$

92,080



15

%

Polymers

$

17,431


$

21,146



(18)

%


$

53,783


$

63,884



(16)

%

Specialty Products

$

2,653


$

990



168

%


$

6,543


$

7,711



(15)

%

Segment Operating
   Income

$

51,285


$

44,695



15

%


$

165,996


$

163,675



1

%

Corporate Expenses

$

(23,591)


$

(14,261)



(65)

%


$

(53,962)


$

(47,878)



(13)

%

Consolidated Operating 
 
Income

$

27,694


$

30,434



(9)

%


$

112,034


$

115,797



(3)

%

* The 2017 operating income line items have been immaterially changed from the amounts originally reported as a result of the Company's first quarter 2018 adoption of ASU No. 2017-07 Compensation-Retirement Benefits (Topic 715).

Total segment operating income increased $6.6 million , or 15%, versus the prior year quarter. Total segment operating income for the first nine months of 2018 increased $2.3 million , or 1%, versus the prior year.

  • Surfactant net sales were $346.9 million for the quarter, an 8% increase versus the prior year. Sales volume increased 9% in total and 4% excluding the first quarter acquisition in Mexico . The organic growth was mostly due to higher North American consumer product and oilfield volumes. Higher North American agricultural volumes and higher sales to the Company's distribution partners also contributed to this increase. The translation impact of a stronger U.S. dollar decreased net sales by 3%. Selling prices increased 2% versus the prior year quarter. Surfactant operating income increased $8.6 million , or 38% versus the prior year, primarily due to higher volumes, a more favorable product mix and improved internal efficiencies.

  • Polymer net sales were $141.6 million for the quarter, down 4% versus the prior year. Total sales volume declined 1% despite a 4% increase in global rigid polyol volumes. The lower total sales volume was principally due to lower phthalic anhydride volumes. The translation impact of a stronger U.S. dollar negatively impacted net sales by 1% while selling prices declined by 2%. Polymer operating income decreased by $3.7 million versus the prior year quarter mostly due to lower margins.

  • Specialty Product net sales were $19.5 million for the quarter, a 5% increase versus the prior year. Operating income increased $1.7 million versus the prior year quarter primarily due to favorable order timing differences within our pharmaceutical and flavor businesses which compensated for some of the first half shortfall.

Corporate Expenses



Three Months Ended

September 30

Nine Months Ended

September 30


($ in thousands)


2018


2017


%

Change



2018


2017


%

Change


Total  -  Corporate Expenses


$

23,591


$

14,261



65

%


$

53,962


$

47,878



13

%

Deferred Compensation
Expense/(Income) *


$

4,222


$

(129)


NM



$

4,971


$

5,263



(6)

%

Business Restructuring Expense


$

1,715


$

426



303

%


$

2,346


$

1,798



30

%

Adjusted Corporate Expense


$

17,654


$

13,964



26

%


$

46,645


$

40,817



14

%

* See Table III for a discussion of deferred compensation plan accounting.

  • Corporate expenses, excluding deferred compensation and business restructuring expenses, increased $3.7 million , or 26% for the quarter. The quarterly increase was primarily due to previously disclosed employee separation costs, higher salaries and higher incentive-based compensation expense.

Income Taxes

The effective tax rate was 18.6% for the first nine months of 2018 versus 26.2% for the first nine months of 2017.  This decrease was primarily attributable to a lower U.S. statutory tax rate of 21% in the first nine months of 2018 versus 35% in the first nine months of 2017.  The Company expects its full year effective tax rate to be in the range of 19% to 22%.

Shareholder Return

The Company paid $5.1 million of dividends to shareholders in the third quarter.  For the first nine months of 2018 the Company has paid $15.2 million of dividends and repurchased $13.5 million of Company stock.  The Company has 520,275 shares remaining under its Board of Directors' share repurchase authorization plan.  With the increased cash dividend in the fourth quarter of 2018, the Company has increased its dividend on the Company's common stock for the 51 st consecutive year.

Selected Balance Sheet Information

The Company's net debt level decreased $17.9 million for the quarter while the net debt ratio dropped from 4% to 2%, mainly attributable to a $17.3 million increase in cash.

 ($ in millions)


9/30/18


6/30/18


3/31/18


12/31/17


Net Debt














Total Debt


$

286.2


$

286.8


$

290.8


$

290.8


Cash



274.0



256.7



244.6



298.9


Net Debt


$

12.2


$

30.1


$

46.2


$

(8.1)


Equity



777.7



761.2



774.6



740.1


Net Debt + Equity


$

789.9


$

791.3


$

820.8


$

732.0


Net Debt / (Net Debt + Equity)



2

%


4

%


6

%


-1

%

The major working capital components were:

 ($ in millions)


9/30/18


6/30/18


3/31/18


12/31/17

Net Receivables


$

323.1


$

312.2


$

325.3


$

293.5

Inventories



195.2



188.5



187.7



172.7

Accounts Payable



(209.3)



(201.3)



(202.4)



(205.0)



$

309.0


$

299.4


$

310.6


$

261.2

Capital spending was $19.2 million during the quarter and $62.9 million during the first nine months of 2018.  This compares to $19.6 million and $57.9 million in the prior year quarter and first nine months, respectively.  For the full year, capital expenditures are expected to be between $90 million and $100 million .

Outlook

"Reported net income for the first nine months of 2018 is up 5% and adjusted net income is up 7%, both reflecting record earnings.  We remain optimistic that the Company will deliver full year growth," said F. Quinn Stepan, Jr. , Chairman, President and Chief Executive Officer.  "We believe our Surfactant business will continue to benefit from our diversification efforts into functional products, new technologies, improved internal efficiencies and expanded sales into our broad customer base globally.  Although margins will continue to challenge us in our North American Polymer business we believe we will continue to benefit from the growing global market for insulation materials.  We believe full year Specialty Product results should improve over 2017."

Conference Call

Stepan Company will host a conference call to discuss the third quarter results at 10:00 a.m. ET ( 9:00 a.m. CT ) on October 24, 2018 . The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (866) 394-0807, and the webcast can be accessed through the Investor Relations/Conference Calls page at www.stepan.com . A webcast replay of the conference call will be available at the same location shortly after the call.

Supporting Slides

Slides supporting this press release will be made available at www.stepan.com at the Investor Relations page at approximately the same time as this press release is issued.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.  Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds and in agricultural and oilfield solutions.  The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

Headquartered in Northfield, Illinois , Stepan utilizes a network of modern production facilities located in North and South America , Europe and Asia .

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL.  For more information about Stepan Company please visit the Company online at www.stepan.com

Contact: Luis E. Rojo , (847) 446-7500

Tables follow

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to disruptions in production or accidents at manufacturing facilities, global competition, volatility of raw material and energy costs, disruptions in transportation or significant changes in transportation costs, reduced demand due to customer product reformulations or new technologies, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, maintaining and protecting intellectual property rights, international business risks, including currency exchange rate fluctuations, legal restrictions and taxes, the impact of changes in the tax code as a result of recent federal tax legislation and uncertainty as to how some of those changes may be applied, our ability to estimate and maintain appropriate levels of recorded liabilities, our debt covenants, our ability to access capital markets, downturns in certain industries and general economic downturns, global political, military, security or other instability, costs related to expansion or other capital projects, interruption or breaches of information technology systems, the costs and other effects of governmental regulation and legal and administrative proceedings and our ability to retain executive management and key personnel.

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Table I

STEPAN COMPANY

For the Three and Nine Months Ended September 30, 2018 and 2017

(Unaudited – in thousands, except per share data)










Three Months Ended

September 30


Nine Months Ended

September 30




2018


2017


2018


2017

Net Sales


$

507,997


$

487,814


$

1,527,198


$

1,451,184

Cost of Sales *



423,872



412,238



1,264,223



1,193,501

Gross Profit *



84,125



75,576



262,975



257,683

Operating Expenses:













Selling *



14,613



13,710



42,872



40,396

Administrative  *



21,904



18,480



59,441



54,141

Research, Development and Technical Services *



13,977



12,655



41,311



40,288

Deferred Compensation (Income) Expense



4,222



(129)



4,971



5,263




54,716



44,716



148,595



140,088














Business Restructuring



1,715



426



2,346



1,798














Operating Income *



27,694



30,434



112,034



115,797














Other Income (Expense):













Interest, Net



(2,797)



(2,763)



(8,620)



(8,618)

Other, Net *



346



1,641



1,990



3,526




(2,451)



(1,122)



(6,630)



(5,092)














Income Before Income Taxes



25,243



29,312



105,404



110,705

Provision for Income Taxes



3,075



7,459



19,597



29,044

Net Income



22,168



21,853



85,807



81,661

Net Income (Income) Loss Attributable to Noncontrolling Interests



-



46



9



33

Net Income Attributable to Stepan Company


$

22,168


$

21,899


$

85,816


$

81,694

Net Income Per Common Share Attributable to Stepan Company













Basic


$

0.96


$

0.95


$

3.73


$

3.56

Diluted


$

0.95


$

0.94


$

3.68


$

3.50

Shares Used to Compute Net Income Per Common

Share Attributable to Stepan Company













Basic



22,986



22,971



23,036



22,941

Diluted



23,288



23,374



23,324



23,361



























* The 2017 amounts for the noted line items have been immaterially changed from the amounts originally reported as a result of the Company's first quarter 2018 adoption of ASU No. 2017-07 Compensation – Retirement Benefits (Topic 715) .  The changes reflect line item reclassifications only and have no impact on pre-tax income or net income.

Table II

Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share *




Three Months Ended

September 30


Nine Months Ended

September 30


($ in thousands, except per
share amounts)


2018


EPS


2017


EPS


2018


EPS


2017


EPS


Net Income Reported


$

22,168


$

0.95


$

21,899


$

0.94


$

85,816


$

3.68


$

81,694


$

3.50






















































Deferred Compensation
(Income) Expense


$

2,610


$

0.11


$

(771)


$

(0.03)


$

2,633


$

0.11


$

965


$

0.04


Business Restructuring



1,187


$

0.05



320


$

0.01



1,660


$

0.07


$

1,382


$

0.06




























Adjusted Net Income


$

25,965


$

1.11


$

21,448


$

0.92


$

90,109


$

3.86


$

84,041


$

3.60


* All amounts in this table are presented after-tax

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

Reconciliation of Pre-Tax to After-Tax Adjustments




Three Months Ended

September 30

Nine Months Ended
September 30


($ in thousands, except per
share amounts)


2018


EPS


2017


EPS


2018


EPS


2017


EPS


Pre-Tax Adjustments


























Deferred Compensation
(Income) Expense


$

3,434





$

(1,244)





$

3,465





$

1,557





Business Restructuring



1,715






426





$

2,346





$

1,798





   Total Pre-Tax Adjustments


$

5,149





$

(818)





$

5,811





$

3,355































Cumulative Tax Effect
on Adjustments


$

(1,352)





$

367





$

(1,518)





$

(1,008)































After-Tax Adjustments


$

3,797


$

0.16


$

(451)


$

(0.02)


$

4,293


$

0.18


$

2,347


$

0.10


Table III

Deferred Compensation Plan


The full effect of the deferred compensation plan on quarterly pretax income was $3.4 million of expense versus $1.2 million of income in the prior year. The year to date impact was $3.5 million of expense versus $1.6 million of expense in the prior year.  The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Stepan Company common stock are as follows:




2018


2017




12/31


9/30



6/30



3/31


12/31



9/30



6/30



3/31


Stepan Company


N/A

$

87.01



$

78.01



$

83.18


$

78.97



$

83.66



$

87.14



$

78.81































The deferred compensation income statement impact is summarized below:



Three Months Ended

September 30

Nine Months Ended

September 30


($ in thousands)


2018


2017


2018


2017

Deferred Compensation













Operating Income (Expense)


$

(4,222)


$

129


$

(4,971)


$

(5,263)

Other, net – Mutual Fund Gain



788



1,115



1,506



3,706

Total Pre Tax


$

(3,434)


$

1,244


$

(3,465)


$

(1,557)

Total After Tax


$

(2,610)


$

771


$

(2,633)


$

(965)

Table IV

Effects of Foreign Currency Translation


The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign currency exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  The table below presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and nine month periods ending September 30, 2018 as compared to 2017:


 ($ in millions)


Three Months Ended

September 30


Increase (Decrease)


Decrease

Due to Foreign

Currency

Translation


Nine Months Ended

September 30


Increase

(Decrease)


Increase

Due to Foreign

Currency

Translation




2018



2017








2018



2017








Net Sales


$

508.0



$

487.8


$

20.2


$

(10.7)


$

1,527.2



$

1,451.2


$

76.0


$

11.4


Gross Profit



84.1




75.6



8.5



(1.7)



263.0




257.7



5.3



0.8


Operating Income



27.7




30.4



(2.7)



(1.1)



112.0




115.8



(3.8)



0.2


Pretax Income



25.2




29.3



(4.1)



(0.9)



105.4




110.7



(5.3)



0.5


Table V

Stepan Company

Consolidated Balance Sheets

September 30, 2018 and December 31, 2017




Sept. 30, 2018


Dec. 31, 2017


ASSETS








Current Assets


$

815,032


$

788,736


Property, Plant & Equipment, Net



598,715



598,443


Other Assets



78,484



83,682


Total Assets


$

1,492,231


$

1,470,861


LIABILITIES AND STOCKHOLDERS' EQUITY








Current Liabilities


$

326,883


$

320,253


Deferred Income Taxes



18,798



10,962


Long-term Debt



262,551



268,299


Other Non-current Liabilities



105,585



130,433


Total Stepan Company Stockholders' Equity



777,651



740,096


Noncontrolling Interest



763



818


Total Liabilities and Stockholders' Equity


$

1,492,231


$

1,470,861


Cision

View original content: http://www.prnewswire.com/news-releases/stepan-reports-third-quarter-results-and-record-nine-month-earnings-300736707.html